Viewing Study NCT01074385



Ignite Creation Date: 2024-05-05 @ 10:19 PM
Last Modification Date: 2024-10-26 @ 10:16 AM
Study NCT ID: NCT01074385
Status: COMPLETED
Last Update Posted: 2013-09-16
First Post: 2010-02-22

Brief Title: Dignity Therapy in mCRC to Increase Peaceful Awareness Impact Goals of Care Decision-Making
Sponsor: Northwestern University
Organization: Northwestern University

Study Overview

Official Title: Use of Dignity Therapy in Stage IV Colorectal Cancer Patients Receiving Chemotherapy to Increase Peaceful Awareness and Impact Goals of Care Decision-Making
Status: COMPLETED
Status Verified Date: 2013-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to try and improve the way that patients with colon cancer understand and cope with their illness and give them tools for talking with their loved ones and family about their illness
Detailed Description: Dignity Therapy is a well tolerated structured interview that helps patients reflect on who they are what is most important to them and what lessons they have learned through life For patients not receiving chemotherapy Dignity Therapy gave patients more hope more meaning in their life and helped their families Researchers at Northwestern University would like to see if it has the same effect in patients getting chemotherapy We will also see if the Dignity Therapy changes patients understanding of their disease and their medical preferences

All study procedures will take place when participants come for a scheduled doctors visit or to receive chemotherapy At the first visit participants will answer a questionnaire taking approximately 15-30 minutes Participants will then have a Dignity Therapy Session approximately 1-2 weeks later A second Dignity Therapy Session will be scheduled again in another 1-2 weeks Each study Dignity Therapy Session will take approximately an hour One to two weeks later a repeat questionnaire will be filled out Finally a third and final questionnaire will be complete 4 weeks later

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
NCI-2010-01851 OTHER NCI CTRP None
STU00022908 OTHER None None